Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease

被引:22
|
作者
Zhu, Kai [1 ,2 ]
Li, Jun [1 ,2 ]
Wang, Yulin [1 ,2 ]
Lai, Hao [1 ,2 ]
Wang, Chunsheng [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200032, Peoples R China
[2] Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China
基金
美国国家科学基金会;
关键词
IRON-OXIDE NANOPARTICLES; GENE DELIVERY; GROWTH-FACTOR; PLASMID DNA; IN-VIVO; TRACKING; TRANSFECTION; RETENTION; CYTOTOXICITY; EFFICIENCY;
D O I
10.1155/2016/1384658
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cell therapy has attracted increasing attention as a promising treatment strategy for cardiac repair in ischemic heart disease. Nanoparticles (NPs), with their superior physical and chemical properties, have been widely utilized to assist stem cell therapy. With the help of NPs, stem cells can be genetically engineered for enhanced paracrine profile. To further understand the fate and behaviors of stem cells in ischemic myocardium, imaging NPs can label stem cells and be tracked in vivo under multiple modalities. Besides that, NPs can also be used to enhance stem cell retention in myocardium. These facts have raised efforts on the development of more intelligent and multifunctional NPs for cellular application. Herein, an overview of the applications of NPs-assisted stem cell therapy is given. Key issues and future prospects are also critically addressed.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Mesoporous silica nanoparticles-assisted ruthenium(Ⅱ) complexes for live cell staining
    Jia Wen
    Hui Yan
    Pengyi Xia
    Yongqian Xu
    Hongjuan Li
    Shiguo Sun
    Science China(Chemistry), 2017, 60 (06) : 799 - 805
  • [32] Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease
    Chao, Ting-Hsing
    Chen, I-Chih
    Tseng, Shi-Ya
    Li, Yi-Heng
    ACTA CARDIOLOGICA SINICA, 2014, 30 (05) : 365 - 374
  • [33] Mesoporous silica nanoparticles-assisted ruthenium(II) complexes for live cell staining
    Wen, Jia
    Yan, Hui
    Xia, Pengyi
    Xu, Yongqian
    Li, Hongjuan
    Sun, Shiguo
    SCIENCE CHINA-CHEMISTRY, 2017, 60 (06) : 799 - 805
  • [34] Mesenchymal stem cell therapy for heart disease
    Gnecchi, Massimiliano
    Danieli, Patrizia
    Cervio, Elisabetta
    VASCULAR PHARMACOLOGY, 2012, 57 (01) : 48 - 55
  • [35] Mesenchymal stem cell therapy in heart disease
    Lopes, Joao Pedro
    Fiarresga, Antonio
    Cunha, Pedro Silva
    Feliciano, Joana
    Ferreira, Rui Cruz
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (01) : 43 - 47
  • [36] Stem Cell Therapy and Congenital Heart Disease
    Nelson, Timothy J.
    Peral, Susana Cantero
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2016, 3 (03):
  • [37] Challenges for heart disease stem cell therapy
    Hoover-Plow, Jane
    Gong, Yanqing
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 99 - 113
  • [38] Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis
    Jeong, Hyunsuk
    Yim, Hyeon Woo
    Park, Hun-Jun
    Cho, Youngseung
    Hong, Hanter
    Kim, Na Jin
    Oh, Il-Hoan
    INTERNATIONAL JOURNAL OF STEM CELLS, 2018, 11 (01) : 1 - 12
  • [39] Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Safe but Not Effective?
    Jamaiyar, Anurag
    Tzani, Aspasia
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (09)
  • [40] Mesenchymal stromal cell therapy in ischemic heart disease
    Kastrup, Jens
    Mygind, Naja Dam
    Qayyum, Abbas Ali
    Mathiasen, Anders Bruun
    Haack-Sorensen, Mandana
    Ekblond, Annette
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2016, 50 (5-6) : 293 - 299